Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Alliance Resource
Arch Resources, Inc. Class A Common Stock
Braveheart Bio, Inc. - Common Stock
Calyxt, Inc. - Common Stock
Coherus Oncology, Inc. - Common Stock
Insight Molecular Diagnostics Inc. - Common Stock
Lexeo Therapeutics, Inc. - Common Stock
Lionsgate Studios Corp. - Common Shares
Mineralys Therapeutics, Inc. - Common Stock
NanoViricides, Inc. Common Stock
OraSure Technologies, Inc. - Common Stock
Pasofino Gold Ltd
Roundhill Magnificent Seven ETF
STARWOOD PROPERTY TRUST, INC. Starwood Property Trust Inc.
Teucrium Wheat Fund ETV
U.S. Global Sea to Sky Cargo ETF
U.S. Global Technology and Aerospace & Defense ETF
US Global GO Gold and Precious Metal Miners ETF
Xenon Pharmaceuticals Inc. - Common Shares
Edit Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Braveheart Bio, Inc.
Braveheart Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
November 10, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London
November 09, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026
November 06, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026
October 30, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
October 30, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
September 16, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
September 08, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio to Participate in Cantor Global Healthcare Conference
September 01, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 07, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Tickers
BRVE
Braveheart Bio Announces Pricing of Upsized Initial Public Offering
August 05, 2026
From
Braveheart Bio, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.